Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Contribution of Glial Cells to Polyglutamine Diseases: Observations from Patients and Mouse Models

Neurotherapeutics(2023)10.1007/s13311-023-01357-5Source: DataRank Database

Contribution of Glial Cells to Polyglutamine Diseases: Observations from Patients and Mouse Models is a research paper published in Neurotherapeutics (2023). On theSindex it has a DataRank of 0. It has been cited 11 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access11 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)OA: bronzeTopics (33)IDs (PubMed, PMC)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (2)

Michelle Gray ORCID,Marija Cvetanović ORCID

Live enrichment

PubMed:37020152 PMC:PMC10119372

National Institute of Neurological Disorders and Stroke

Grant: NS197397

National Institute of Neurological Disorders and Stroke

Grant: NS109077

National Institute of Neurological Disorders and Stroke

Grant: NS089750

National Institute of Neurological Disorders and Stroke

Grant: NS089750-01A1 (MG)

NINDS NIH HHS

Grant: R01 NS107387

NINDS NIH HHS

Grant: R01 NS109077

NINDS NIH HHS

Grant: R01 NS089750

National Institutes of Health

Grant: 3R01NS089750-10S1

Exploring the contribution of astrocytes to Huntington disease

National Institutes of Health

Grant: 5R01NS109077-04

Etiology of cognitive decline in Spinocerebellar ataxia type 1

bronzeLicense: Elsevier Non-Commercial

publisherhttps://link.springer.com/content/pdf/10.1007/s13311-023-01357-5.pdf

publisherhttps://link.springer.com/article/10.1007/s13311-023-01357-5/fulltext.html

publisherhttps://api.elsevier.com/content/article/PII:S1878747923001058?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S1878747923001058?httpAccept=text/plain

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC10119372/pdf/13311_2023_Article_1357.pdf

Fields of Study

03 medical and health sciences0302 clinical medicineMiceAnimalsHuntington DiseaseNeuronsSpinocerebellar AtaxiasNeurogliaDisease Models, AnimalMice, TransgenicPeptides

MeSH Terms

NeurogliaNeuronsAnimalsMice, TransgenicMiceHuntington DiseaseSpinocerebellar AtaxiasDisease Models, AnimalPeptides

Keywords

Spinocerebellar ataxiaGliaHuntington’s DiseasePolyglutamineNeuronsMiceDisease Models, AnimalHuntington DiseaseAnimalsSpinocerebellar AtaxiasMice, TransgenicPeptidesNeuroglia